Red Blood Cell Transfusion in ECMO - A Feasibility Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Red Blood Cell Transfusion in ECMO - A Feasibility Trial — Stella

Recruiting

Back to Blood Loss Anemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Australia

Royal Prince Alfred Hospital, Camperdown, New South Wales

St Vincent's Health Sydney, Sydney, New South Wales

Key details

Sponsor

Australian and New Zealand Intensive Care Research Centre

Enrollment target

~120 participants

Started

September 2023

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov